PI 828 |
| Catalog No.GC10386 |
Le PI 828 est un inhibiteur double de PI3K et de la caséine kinase 2 (CK2) avec des CI50 de 173 nM, 149 nM et 1127 nM pour p110α, CK2 et CK2α2 dans le dosage de la lipide kinase, respectivement.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 942289-87-4
Sample solution is provided at 25 µL, 10mM.
Product has been cited by 1 publications
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 942289-87-4 | SDF | |
| Chemical Name | 8-(4-aminophenyl)-2-morpholino-4H-chromen-4-one | ||
| Canonical SMILES | O=C1C2=CC=CC(C(C=C3)=CC=C3N)=C2OC(N4CCOCC4)=C1 | ||
| Formula | C19H18N2O3 | M.Wt | 322.36 |
| Solubility | DMF: 25 mg/ml,DMSO: 25 mg/ml,Ethanol: slightly soluble | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.1021 mL | 15.5106 mL | 31.0212 mL |
| 5 mM | 0.6204 mL | 3.1021 mL | 6.2042 mL |
| 10 mM | 0.3102 mL | 1.5511 mL | 3.1021 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC15766 Kisspeptin 10 (rat)
- GC15853 Genz-644282
- GC41696 (Ala1)-PAR4 (1-6) (mouse) (trifluoroacetate salt)
- GC50115 ASP 7663
- GC13633 Ciprofibrate
- GC40184 Probenecid-d14
- GC11108 Abiraterone acetate
- GC39426 PROTAC SGK3 degrader-1
- GC13100 [Ala92]-p16 (84-103)
- GC33660 Dulcite (Dulcitol)
- GC40709 C2 L-threo Ceramide (d18:1/2:0)
- GC33771 Metadoxine
- GC32406 H3B-6545
- GC18771 Resveratrol-4'-O-D-Glucuronide
- GC39349 BIZ 114
- GC37752 Tectorigenin 7-O-Xylosyl Glucoside
Avis
Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *